Intravenous immunoglobulin treatment recovers the down-regulated levels of Th1 cytokines in the sera and skin of scleroderma patients

MLA

Kudo, Hideo, et al. “Intravenous Immunoglobulin Treatment Recovers the Down-Regulated Levels of Th1 Cytokines in the Sera and Skin of Scleroderma Patients.” Journal of Dermatological Science, vol. 69, no. 1, Jan. 2013, pp. 77–80. EBSCOhost, https://doi.org/10.1016/j.jdermsci.2012.09.010.

APA

Kudo, H., Jinnin, M., Yamane, K., Makino, T., Kajihara, I., Makino, K., Honda, N., Nakayama, W., Fukushima, S., & Ihn, H. (2013). Intravenous immunoglobulin treatment recovers the down-regulated levels of Th1 cytokines in the sera and skin of scleroderma patients. Journal of Dermatological Science, 69(1), 77–80. https://doi.org/10.1016/j.jdermsci.2012.09.010

Chicago

Kudo, Hideo, Masatoshi Jinnin, Keitaro Yamane, Takamitsu Makino, Ikko Kajihara, Katsunari Makino, Noritoshi Honda, Wakana Nakayama, Satoshi Fukushima, and Hironobu Ihn. 2013. “Intravenous Immunoglobulin Treatment Recovers the Down-Regulated Levels of Th1 Cytokines in the Sera and Skin of Scleroderma Patients.” Journal of Dermatological Science 69 (1): 77–80. doi:10.1016/j.jdermsci.2012.09.010.